ArticleFood & nutrition research2026
Effects of curcumin on depression, anxiety, and stress symptoms in adults: a GRADE-assessed systematic review and dose-response meta-analysis.
Article in Food & nutrition research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Curcumin, a bioactive polyphenol extracted from Objective: This systematic review and dose-response meta-analysis aimed to quantitatively assess the effects of curcumin supplementation on depression, anxiety, and stress in adults. Methods: Electronic databases including PubMed, Scopus, Web of Science, and Google Scholar were searched up to December 2025 for RCTs. Two reviewers independently conducted study selection, data extraction, and risk-of-bias assessment. Pooled standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated. Subgroup, meta-regression, sensitivity, dose-response, and time-response analyses were conducted. Moreover, publication bias and certainty of evidence were evaluated. The study protocol was registered in the PROSPERO database (CRD420251208049). Results: Twenty-six RCTs encompassing 1,491 participants were included. Curcumin supplementation significantly reduced symptoms of depression (SMD = -1.53; 95% CI: -2.05 to -1.02), anxiety (SMD = -1.67; 95% CI: -2.42 to -0.93), and stress (SMD = -1.71; 95% CI: -3.37 to -0.06) compared with placebo. Dose-response analysis indicated a significant nonlinear association, suggesting that higher curcumin doses (>1.5 g/day) were associated with greater reductions in depressive symptoms. Subgroup analyses showed slightly greater improvements among female participants and those experiencing psychological distress. Conclusions: Curcumin supplementation may provide a potential benefit for depression, anxiety, and stress; however, substantial between-study heterogeneity and moderate-to-low certainty of evidence limit confidence in the generalizability of these findings. Further well-designed RCTs are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.